Under this agreement NorthX will manufacture Lipum´s lead asset,
Janet Hoogstraate, CEO of NorthX Biologics added “We are excited to be working on
About
NorthX Biologics, a leading
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.85 SEK | +2.24% | +7.87% | +5.06% |
06/05 | Lipum Obtains SEK20 Million Loan from Flerie Invest | MT |
02/04 | Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer | CI |
Under this agreement NorthX will manufacture Lipum´s lead asset,
Janet Hoogstraate, CEO of NorthX Biologics added “We are excited to be working on
About
NorthX Biologics, a leading
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+5.06% | 13.79M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |